Skip to main content
OpenTrials
Completed

NCT Number: NCT00184353

Clinical MR Spectroscopy of Brain Metastases at 1,5T and 3T.

Increasing magnetic field is known to give improvements in signal-to-noise-ratio (SNR) and spectral resolution. To investigate this, spectra from different subjects were examined using two clinical MR instruments operating at 1.5T and 3T respectively.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Norwegian University of Science and Technology

Trondheim, N-7489, Norway

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • brain metastases

Exclusion criteria

  • children
  • pregnancy

Sponsors and collaborators

Lead sponsor

Norwegian University of Science and Technology

Other

Collaborators

  • The Royal Norwegian Ministry of Health

Registry information

Official study title

In Vivo Proton MR Spectroscopy of Brain Metastases Obtained at 1,5T and 3T.

Important dates

Study start
2003
Primary completion
2004
Study completion
2005
First posted
Sep 16, 2005
Registry last updated
Oct 21, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.